Citadel Advisors’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$605K Sell
43,500
-40,300
-48% -$553K ﹤0.01% 8834
2025
Q4
$1.16M Buy
83,800
+69,300
+478% +$1.63M ﹤0.01% 7073
2025
Q3
$354K Sell
14,500
-3,900
-21% -$95K ﹤0.01% 9963
2025
Q2
$425K Buy
18,400
+1,700
+10% +$44.8K ﹤0.01% 9013
2025
Q1
$451K Sell
16,700
-19,300
-54% -$728K ﹤0.01% 8701
2024
Q4
$1.93M Sell
36,000
-15,100
-30% -$799K ﹤0.01% 5712
2024
Q3
$2.32M Buy
51,100
+21,700
+74% +$944K ﹤0.01% 5253
2024
Q2
$1.23M Sell
29,400
-22,600
-43% -$1.06M ﹤0.01% 6194
2024
Q1
$1.96M Buy
52,000
+51,300
+7,329% +$1.12M ﹤0.01% 5564
2023
Q4
$7.51K Buy
700
+300
+75% +$2.59K ﹤0.01% 13284
2023
Q3
$4.03K Sell
400
-1,000
-71% -$11.5K ﹤0.01% 13523
2023
Q2
$16.6K Sell
1,400
-700
-33% -$9.36K ﹤0.01% 12891
2023
Q1
$25.4K Buy
2,100
+500
+31% +$8.32K ﹤0.01% 12873
2022
Q4
$21.1K Buy
+1,600
New +$23.4K ﹤0.01% 13109

Other funds holding JANX